Table 2.
Analytes | Linear Range (µg/L) | Matrix-Matched Calibration (R2) | Cm | ME | MDLn (µg/kg) | MQL (µg/kg) | Accuracy | Precision | ||
---|---|---|---|---|---|---|---|---|---|---|
Recovery (% ± SD) | Mean Recovery (% ± SD) | Intra-Day Precision (RSD %) | Inter-Day Precision (RSD %) | |||||||
Morphine | 0.01–5000 | y = 3269x + 32,452 (0.999) | 92 | 64 | 0.07 | 0.24 | 50 ± 1 a | 46 ± 2 | 4 a | 11 a |
42 ± 2 b | 2 b | 5 b | ||||||||
Codeine | 0.01–5000 | y = 2554x + 29,642 (0.999) | 96 | 86 | 0.07 | 0.24 | 64 ± 2 a | 68 ± 4 | 3 a | 8 a |
71 ± 6 b | 2 b | 4 b | ||||||||
Thebaine | 0.1–5000 | y = 10,093x + 485,953 (0.999) | 96 | 109 | 0.72 | 2.40 | 72 ± 3 a | 74 ± 4 | 5 a | 7 a |
76 ± 4 b | 0 b | 4 b | ||||||||
Papaverine | 0.01–5000 | y = 33,441x + 2,814,320 (0.999) | 92 | 80 | 0.07 | 0.24 | 116 ± 5 a | 109 ± 3 | 5 a | 9 a |
101 ± 1 b | 2 b | 7 b | ||||||||
Noscapine | 0.01–5000 | y = 42,914x + 1,631,091 (0.999) | 94 | 65 | 0.07 | 0.24 | 109 ± 1 a | 103 ± 1 | 4 a | 10 a |
97 ± 1 b | 3 b | 8 b | ||||||||
Oripavine | 10–5000 | y = 1080x − 31,137 (0.999) | 94 | 31 | 72.07 | 240 | 51 ± 3 a | 52 ± 3 | 3 a | 5 a |
53 ± 3 b | 3 b | 5 b |
Cm: linearity coefficient calculated by (1-(SD/average slope)) × 100, where SD is the standard deviation of the calibration slopes obtained on different days; ME: matrix effect calculated by dividing the purified matrix slope by the solvent slope. MDL: method detection limit. MQL: method quantification limit estimated as 3 and 10 times the signal/noise ratio, respectively. Accuracy (mean recovery obtained from six samples, n = 6) and precision were obtained by spiking samples at two known concentration levels: a low spiked level (0.1 mg/kg) and b high spiked level (1 mg/kg). Intra-day precision: six consecutive injections (n = 6) on the same day; Inter-day precision: three replicate samples injected in triplicate throughout three different days (n = 9).